Achieve Life Sciences Inc

FSX : SP4P

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc. is based in Vancouver, Canada.

Information

Sector
Healthcare
Industry
Biotechnology
Type
Common Stock
Country
Canada

Price

EUR 4.47

Symbol

SP4P

Type

Common Stock

Previous Close

:

4.42

52 Week Range

:

2.84 - 5.30

Volume

:

250.00

Average Volume

:

200.00

High

:

4.47

Low

:

4.47

Change

:

0.06

Percent change (%)

:

1.25

Disclaimer: Stakeville is a simulation trading game. All trades and stock prices are fictional and do not reflect real-world markets. This game is for entertainment purposes only and does not involve real financial transactions. Read more...